Module Specifications.
Current Academic Year 2024 - 2025
All Module information is indicative, and this portal is an interim interface pending the full upgrade of Coursebuilder and subsequent integration to the new DCU Student Information System (DCU Key).
As such, this is a point in time view of data which will be refreshed periodically. Some fields/data may not yet be available pending the completion of the full Coursebuilder upgrade and integration project. We will post status updates as they become available. Thank you for your patience and understanding.
Date posted: September 2024
| |||||||||||||||||||||||||||||||||||||||||||
None Array |
|||||||||||||||||||||||||||||||||||||||||||
Description To examine the science behind cancer diseases, examine how this translates into rational treatment and equip the graduate with the skills to be proficient, competent and confident to utilise, apply and impart this scientific understanding at the interface of patients and clinician. | |||||||||||||||||||||||||||||||||||||||||||
Learning Outcomes 1. Describe the basic biology and physiology of the cell and how this becomes aberrant to cause cancer 2. Appraise scientific jargon commonly used and explain how to communicate this terminology to healthcare professionals and to translate jargon to layterms for people with cancer and their close others, particularly in the context of patient recruitment to clinical trials and explaining the rationale, benefits and side effects of cancer treatments. 3. Be skilled in explaining the rationale, benefits and side effects of participation in clinical trials and cancer treatments to patients and healthcare professionals using language appropriate to the context. 4. Evaluate diagnostic, prognostic and treatment challenges and the process by which new research advances are undertaken and applied in the oncology clinical setting. 5. Appraise the major treatments for cancer (drug, radiation, biological and surgery), their effects and side effects; 6. Critique the implications of current and future technologies relevant to treatment, management and care for patients with cancer | |||||||||||||||||||||||||||||||||||||||||||
All module information is indicative and subject to change. For further information,students are advised to refer to the University's Marks and Standards and Programme Specific Regulations at: http://www.dcu.ie/registry/examinations/index.shtml |
|||||||||||||||||||||||||||||||||||||||||||
Indicative Content and Learning Activities
Scientific models and theories•Scientific models and theories of the biochemical, molecular, genetic, epigenetic and environmental origins of cancerTreatment guidelines and decision trees•Treatment guidelines and decision trees associated with the major common forms of cancer, e.g. breast, lung, prostate and haematological malignancies, and how these are impacted by the molecular origins of these diseasesStaging criteria•Staging criteria for the major forms of cancer, what these stages mean in terms of the state of the disease in the body and their consequences for the patient.Diagnostic, prognostic and predictive tools•Diagnostic, prognostic and predictive tools applied in cancer treatmentCommon morbidities and co-morbidities•Common morbidities and co-morbidities directly and indirectly associated with cancer.Resistance pharmacology•Models of challenges in cancer treatment, how tumours can resist and overcome the various forms of therapy availableEmerging trends and technologies•Emerging trends in cancer research, diagnosis and treatmentCommunications knowledge and skills•Communications knowledge and skills appropriate to the transfer of oncology terminology in professional and lay terms for healthcare professionals to educate/offer effective and clear explanations to people with cancer and their close others in clinical and community settings re recruitment to clinical trials and understanding cancer/treatments/interventions/prevention | |||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||
Indicative Reading List
| |||||||||||||||||||||||||||||||||||||||||||
Other Resources 197, http://www.bccancer.bc.ca/PPI/default.htm, 0, 198, http://www.cancer.org/docroot/home/index.asp, 0, 199, http://www.cancer.net/portal/site/patient/, 0, 200, http://www.cancerbackup.org.uk/Home, 0, 201, http://www.cancer.gov/cancertopics/understandingca, 0, 202, Video series, Fallowfield, L, Jenkins,V., 0, Communication with patients with cancer: Teaching series: Clinical Trials , Sussex, | |||||||||||||||||||||||||||||||||||||||||||